Ohio Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 33 (65% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 9,422
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 22.85%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,903
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 20.06%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 74.81% 78.30%
White, Hispanic/Latino Patients 3.73% 3.05%
Black/African American, Non-Hispanic/Latino Patients 14.34% 12.87%
Black/African American, Hispanic/Latino Patients 0.33% 0.53%
Asian Patients3 0.42% 0.11%
American Indian/Alaska Native Patients3 0.17% 0.21%
Native Hawaiian/Other Pacific Islander Patients3 0.24% 0.11%
Patients with More than one race3 1.77% 1.68%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.16% 1.10%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.64% 0.47%
Unreported/Refused to Report Race and Ethnicity 2.39% 1.58%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,617
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 40.48%
COVID-19 Immunization Series Completed 1,464
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 39.39%
COVID-19 Immunization Series Additional 198
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 19.44%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 56.28% 58.54% 73.23%
White, Hispanic/Latino Patients 6.80% 6.28% 3.54%
Black/African American, Non-Hispanic/Latino Patients 26.16% 25.14% 8.59%
Black/African American, Hispanic/Latino Patients 0.43% 0.55% 0.00%
Asian Patients3 0.19% 1.23% 2.53%
American Indian/Alaska Native Patients3 0.25% 0.07% 2.02%
Native Hawaiian/Other Pacific Islander Patients3 0.12% 0.48% 0.00%
Patients with More than one race3 1.55% 1.23% 1.01%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.78% 3.07% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.92% 1.78% 0.51%
Unreported/Refused to Report Race and Ethnicity 3.53% 1.64% 8.59%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 30.30%
1 to 24 Hours 33.33%
More Than 24 Hours 36.36%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 6.06%
Staffing to administer the vaccine 18.18%
Vaccine confidence 48.48%
Vaccine storage capacity 3.03%
Vaccine supply 0.00%
Other 12.12%
None 36.36%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 98.18%
Average Percent of Health Center Visits Conducted Virtually 16.97%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 21.21%
Number of Mobile Van Sites 7
Number of Pop-up Clinics 17
Number of School-Based Vaccination Sites 7

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 3.03%
Refer patients to another organization that provides monoclonal antibody therapies 48.48%
None 48.48%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 12.12%
Patient awareness/education 6.06%
Staffing capacity 21.21%
Therapy administration/onsite logistics 24.24%
Other 9.09%
None 51.52%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021